CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Italfarmaco

For profitContributed to NMEWebsite ↗

Also known as: Italfarmaco | Italfarmaco S.A | ITALFARMACO SA | Italfarmaco S.p.A. | ITALFARMACO SPA

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Oct 1, 2003

First marketed drug

Nov 23, 2016

First NDA

Mar 21, 2024

Last known activity

May 7, 2025

Timeline

1930s

  1. Jun 1, 1938

    Italfarmaco— Founded

1980s

  1. Jun 1, 1984

    Chemi SpA— Acquired

2010s

  1. Sep 22, 2017

    decitabine— Marketing Organization

  2. Sep 5, 2018

    riluzole— NDA Secondary Org

2020s

  1. Mar 21, 2024

    givinostat— NDA Organization

Drugs by trial phase (12 distinct, 31 trials)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (4)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (35)

Details

Founded
Milan, IT Jun 1, 1938
First NDA
Mar 21, 2024
Last known activity
May 7, 2025

Designations held

  • Orphan drug
  • Fast track
  • Priority review